A Phase I Trial of Doxil, Bevacizumab and Temsirolimus

Trial Profile

A Phase I Trial of Doxil, Bevacizumab and Temsirolimus

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Doxorubicin liposomal (Primary) ; Temsirolimus (Primary) ; Everolimus
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 May 2017 Status changed from completed to active, no longer recruiting.
    • 06 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 07 Jul 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top